Malarone Pediatric en es it fr

Malarone Pediatric Brand names, Malarone Pediatric Analogs

Malarone Pediatric Brand Names Mixture

  • No information avaliable

Malarone Pediatric Chemical_Formula

C22H19ClO3

Malarone Pediatric RX_link

http://www.rxlist.com/cgi/generic/atovaqu.htm

Malarone Pediatric fda sheet

Malarone_Pediatric FDA

Malarone Pediatric msds (material safety sheet)

Malarone Pediatric Synthesis Reference

No information avaliable

Malarone Pediatric Molecular Weight

366.837 g/mol

Malarone Pediatric Melting Point

No information avaliable

Malarone Pediatric H2O Solubility

Practically insoluble

Malarone Pediatric State

Solid

Malarone Pediatric LogP

5.251

Malarone Pediatric Dosage Forms

Suspension; Tablet

Malarone Pediatric Indication

For the treatment or prevention of Pneumocystis carinii pneumonia in patients who are intolerant to trimethoprim-sulfamethoxazole (TMP-SMX). Also indicated for the acute oral treatment of mild to moderate PCP in patients who are intolerant to TMP-SMX.

Malarone Pediatric Pharmacology

Atovaquone is a highly lipophilic drug that closely resembles the structure ubiquinone. Its inhibitory effect being comparable to ubiquinone, in sensitive parasites atovaquone can act by selectively affecting mitochondrial electron transport and parallel processes such as ATP and pyrimidine biosynthesis. For illustration, cytochrome bc1 complex (complex III) seems to serve as a highly discriminating molecular target for atovaquone in Plasmodia

Malarone Pediatric Absorption

The bioavailability of atovaquone is low and variable and is highly dependent on formulation and diet. Bioavailability of the suspension increases two-fold when administered with meals. When administered with food, bioavailability is approximately 47%. Without food, the bioavailability is 23%.

Malarone Pediatric side effects and Toxicity

The median lethal dose is higher than the maximum oral dose tested in mice and rats (1825 mg/kg per day). Overdoses up to 31,500 mg of atovaquone have been reported. In one such patient who also took an unspecified dose of dapsone, methemoglobinemia occurred. Rash has also been reported after overdose.

Malarone Pediatric Patient Information

Malarone Pediatric Organisms Affected

Plasmodium and other